KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Humana (HUM) over the last 17 years, with Q3 2025 value amounting to $1.3 billion.

  • Humana's Net Cash Flow rose 45012.99% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $272.0 million, marking a year-over-year increase of 10271.13%. This contributed to the annual value of -$2.5 billion for FY2024, which is 57384.2% down from last year.
  • As of Q3 2025, Humana's Net Cash Flow stood at $1.3 billion, which was up 45012.99% from -$210.0 million recorded in Q2 2025.
  • In the past 5 years, Humana's Net Cash Flow registered a high of $8.7 billion during Q1 2023, and its lowest value of -$10.5 billion during Q4 2023.
  • Its 5-year average for Net Cash Flow is $37.6 million, with a median of -$210.0 million in 2025.
  • The largest annual percentage gain for Humana's Net Cash Flow in the last 5 years was 80043.2% (2022), contrasted with its biggest fall of 83373.63% (2022).
  • Over the past 5 years, Humana's Net Cash Flow (Quarter) stood at -$910.0 million in 2021, then tumbled by 833.74% to -$8.5 billion in 2022, then decreased by 23.03% to -$10.5 billion in 2023, then skyrocketed by 72.31% to -$2.9 billion in 2024, then surged by 146.56% to $1.3 billion in 2025.
  • Its last three reported values are $1.3 billion in Q3 2025, -$210.0 million for Q2 2025, and $2.0 billion during Q1 2025.